Electrochemotherapy for skin melanoma study
Part of Cancer, Skin clinical trials.
This study tests if electrochemotherapy can change the environment around melanoma tumors. It may help patients with melanoma that has spread to the skin or just under the skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a confirmed diagnosis of skin melanoma (cutaneous melanoma)
- You have tumors in the skin or just under the skin that can be treated with electrochemotherapy
- Your doctor has recommended electrochemotherapy with bleomycin or cisplatin as part of your care
- You are willing and able to give written consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called electrochemotherapy for tumors in internal organs (like the liver or pancreas) when standard treatments are no longer possible. It uses a drug called bleomycin plus electric pulses to target cancer cells.
This study looks at immune and tumor “behavior” markers in people with metastatic melanoma after standard treatment. It may help researchers understand why treatment works for some people and not others by testing blood and skin tumor samples.
This trial tests a treatment that uses your own immune cells, called tumor-infiltrating lymphocytes (TILs), to fight melanoma. Some participants also get a drug called pembrolizumab. The goal is to see if this approach can shrink tumors.
This trial tests a new treatment for advanced melanoma that can be surgically removed. It combines your own immune cells (called gamma-delta T cells) with a drug (interferon or a PD-1 blocker) to see if it helps the body fight the cancer before and after surgery.
This trial tests a new combination immunotherapy for people with advanced melanoma. It aims to help those whose cancer has not been controlled by standard treatments.
This study tests how electrochemotherapy (ECT) changes the area around melanoma tumors in the skin. It may help doctors understand why ECT works and who benefits most.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.